When decisions matter most, expert guidance makes the difference!
EviaSearch provides in-process and troubleshooting advisory services across discovery research, CMC, formulation, scale-up, and clinical development for small and large molecules. Our advisors are experienced industry professionals from pharma, biotech, and CROs, delivering independent, objective guidance during critical execution phases. By engaging early, we help identify root causes, resolve technical and operational bottlenecks, and align cross-functional teams. This enables faster decision-making, reduced development risk, and sustained momentum across programs.
Get expert guidance. Reduce risk. Improve outcomes.
We support early-stage research challenges by identifying data integrity gaps, optimizing experimental design, helping research teams in identifying root causes, optimizing critical process parameters, and ensuring early development decisions support scalable development with downstream manufacturability.
Our advisors support resolution of process inefficiencies, impurity excursions, and scale-up failures by integrating chemistry, process data, and analytical insights into clear corrective actions. Our biological experts address upstream and downstream biologics development challenges, ensuring process robustness, consistency, and alignment with QbD and biosimilar expectations.
We provide formulation troubleshooting across IR, MR, and complex dosage forms—resolving solubility, dissolution, and stability challenges without unnecessary reformulation cycles. Our large molecule experts resolve aggregation, viscosity, and stability challenges in biologic formulations, supporting liquid, lyophilized, and high-concentration products.
We provide independent advisory to conceptualize the trial, help with clinical development strategies, ensure trial design, endpoints, dose rationale, CRO Selection, identify root causes of operational delays and execution failures, recommend practical interventions to improve site performance, enrolment, CRO performance troubleshooting, governance frameworks, and corrective action planning to bring clinical programs back on track.
All our recommendations are aligned with global regulatory and guidance expectations and consider downstream impact on clinical progression, submission strategy, and lifecycle management.